Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics (NASDAQ: AKBA) has announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, before market open. The company will host a conference call at 8:00 a.m. EDT on the same day to discuss the financial results and recent business highlights.
Participants are encouraged to dial in 15 minutes before the scheduled start time to ensure timely connection. A live webcast will be available through Akebia's Investors section website, with an online archive accessible afterward at ir.akebia.com.
Akebia Therapeutics (NASDAQ: AKBA) ha annunciato che pubblicherà i suoi risultati finanziari del primo trimestre 2025 il giovedì 8 maggio 2025, prima dell'apertura dei mercati. La società terrà una conference call alle 8:00 a.m. EDT dello stesso giorno per discutere i risultati finanziari e gli ultimi sviluppi aziendali.
Si consiglia ai partecipanti di collegarsi 15 minuti prima dell'orario previsto per garantire una connessione puntuale. Una diretta webcast sarà disponibile nella sezione Investitori del sito web di Akebia, con un archivio online accessibile successivamente su ir.akebia.com.
Akebia Therapeutics (NASDAQ: AKBA) ha anunciado que publicará sus resultados financieros del primer trimestre de 2025 el jueves 8 de mayo de 2025, antes de la apertura del mercado. La compañía realizará una conferencia telefónica a las 8:00 a.m. EDT el mismo día para analizar los resultados financieros y las novedades recientes del negocio.
Se recomienda a los participantes conectarse 15 minutos antes de la hora programada para asegurar una conexión puntual. Habrá una transmisión en vivo disponible en la sección de Inversores del sitio web de Akebia, con un archivo en línea accesible posteriormente en ir.akebia.com.
Akebia Therapeutics (NASDAQ: AKBA)는 2025년 1분기 재무 결과를 2025년 5월 8일 목요일 장 개장 전에 발표할 예정입니다. 같은 날 동부 표준시 8:00 a.m.에 재무 결과 및 최근 사업 하이라이트에 대해 논의하는 컨퍼런스 콜을 진행합니다.
참가자들은 원활한 연결을 위해 예정된 시작 시간 15분 전에 접속할 것을 권장합니다. Akebia 투자자 섹션 웹사이트를 통해 실시간 웹캐스트가 제공되며, 이후 ir.akebia.com에서 온라인 아카이브를 이용할 수 있습니다.
Akebia Therapeutics (NASDAQ : AKBA) a annoncé qu’elle publierait ses résultats financiers du premier trimestre 2025 le jeudi 8 mai 2025, avant l’ouverture des marchés. La société tiendra une conférence téléphonique à 8h00 EDT le même jour pour discuter des résultats financiers et des faits marquants récents.
Les participants sont invités à se connecter 15 minutes avant l’heure prévue afin d’assurer une connexion ponctuelle. Une diffusion en direct sera disponible via la section Investisseurs du site web d’Akebia, avec une archive en ligne accessible par la suite sur ir.akebia.com.
Akebia Therapeutics (NASDAQ: AKBA) hat angekündigt, dass es seine Finanzergebnisse für das erste Quartal 2025 am Donnerstag, den 8. Mai 2025, vor Markteröffnung veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:00 Uhr EDT eine Telefonkonferenz abhalten, um die Finanzergebnisse und aktuelle Geschäftshighlights zu besprechen.
Teilnehmer werden gebeten, sich 15 Minuten vor Beginn einzuwählen, um eine pünktliche Verbindung sicherzustellen. Ein Live-Webcast wird über den Investor-Bereich auf der Akebia-Website verfügbar sein, mit einem Online-Archiv, das anschließend unter ir.akebia.com zugänglich ist.
- None.
- None.
Akebia to Host Conference Call on May 8, 2025, at 8:00 a.m. EDT
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, prior to the open of financial markets.
Akebia will host a conference call on Thursday, May 8, 2025, at 8:00 a.m. EDT to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
FAQ
When will Akebia Therapeutics (AKBA) report Q1 2025 earnings?
What time is Akebia's Q1 2025 earnings call?
How can investors access Akebia's Q1 2025 earnings call?
Where can I find the replay of Akebia's Q1 2025 earnings call?
